The treatment of cytomegalovirus retinitis in human immunodeficiency virus infection.

Authors

  • E Rabadão Departamento de Doenças Infecciosas, Hospitais da Universidade de Coimbra.
  • V Duque
  • A Meliço-Silvestre

DOI:

https://doi.org/10.20344/amp.2142

Abstract

Most of the patients with immunodeficiency virus infection (75%-85%) are coinfected with cytomegalovirus. It is estimated that cytomegalovirus disease develops in 45% of them, mainly those presenting low CD4 cell counts (< 100/mm3). Retinitis is the most common manifestation of reactivated cytomegalovirus disease (85%), followed by other extra ocular sites (central nervous system, lungs, gastrointestinal system, adrenal glands, etc.). The particularly high incidence of cytomegalovirus retinitis, the difficulties concerning its therapeutical approach and the relatively unsatisfactory results, justify this review, according to the new treatment options presented in recent literature.

Downloads

Download data is not yet available.

How to Cite

1.
Rabadão E, Duque V, Meliço-Silvestre A. The treatment of cytomegalovirus retinitis in human immunodeficiency virus infection. Acta Med Port [Internet]. 1999 Jun. 30 [cited 2023 Feb. 6];12(4-6):203-7. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/2142

Issue

Section

Arquivo Histórico